TrademarkDir
KRIYA RARE DISEASE
DEAD

Serial Number

97213564

Owner

Kriya Therapeutics, Inc.

Attorney

Monica Riva Talley

Filing Date

Jan 11, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KRIYA RARE DISEASE Trademark

Serial Number: 97213564

KRIYA RARE DISEASE is a trademark filed by Kriya Therapeutics, Inc. on January 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Kriya Therapeutics, Inc. (24 trademarks)

Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

January 11, 2022

Registration Date

Not Registered

Published for Opposition

October 4, 2022

Goods & Services

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 1, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 2, 2023 EX1G
SOU EXTENSION 1 FILED
May 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 2, 2023 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 10, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2022 NWOS
NEW APPLICATION ENTERED
Jan 14, 2022 NWAP

Related Trademarks

More from this Owner

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY